Reported sales nil
Net Loss of Parabolic Drugs reported to Rs 7.22 crore in the quarter ended March 2020 as against net loss of Rs 9.43 crore during the previous quarter ended March 2019. There were no Sales reported in the quarter ended March 2020 and during the previous quarter ended March 2019.For the full year,net loss reported to Rs 28.64 crore in the year ended March 2020 as against net loss of Rs 41.40 crore during the previous year ended March 2019. There were no Sales reported in the year ended March 2020 as against Rs 17.98 crore during the previous year ended March 2019.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
